CARA - Cara Therapeutics

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, Jul 25, 2016.

  1. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    34
    Cara Therapeutics announced positive statistically significant results in a phase 2/3 trial for its drug I.V. CR845 which goal is to reduce pain caused by abdominal surgeries. Cara Therapeutics is a small-cap stock, so getting the drug approved will likely have a significant impact on the stock price.
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    The last two sessions have been huge, good work longs!
     
  4. Stock Dragon

    Stock Dragon New Member

    Joined:
    Jul 22, 2019
    Messages:
    3
    Likes Received:
    1
    This stock has amazing potential. I am surprised no one here is talking about it. I am in at $5 and quadrupled already....6,000 shared.
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
    Nice, congrats on the gains. Why is there amazing potential at this point though? Enlighten us!
     
  6. Stock Dragon

    Stock Dragon New Member

    Joined:
    Jul 22, 2019
    Messages:
    3
    Likes Received:
    1
    CARA is moving through the approval process for a pain medication that has been found to also stop itch for Kidney Dialysis patients equals + HUGE market...well into the billions. Zero competition. First in class. The pain medication is an opioid that DOES NOT cause addictive euphoria. Think...breakthrough of the century there....While the pain indication may be coming, it has had some problems in early studies. However, Pruritis Studies are crushing it. I encourage people to research it...its is undervalued at this point...you will thank me later.
     
    T0rm3nted likes this.
  7. Stock Dragon

    Stock Dragon New Member

    Joined:
    Jul 22, 2019
    Messages:
    3
    Likes Received:
    1
    If you are wondering where and who..is behind the company....YALE scientists....Stamford CT. Some industrial buying is starting. Black Rock owns over 2 mm shares.
     
  8. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    4,319
    Likes Received:
    3,375
    Was added to Small Cap 600 earlier this week, you'll notice subsequent huge volume on Tuesday.

    Applied for a Marketing Authorization Application in the EU, for the treatment of pruritus associated with chronic kidney disease in hemodialysis patients. They had positive results from 2 Phase III trials and another 32 clinical trials. Decision expected in Q2 2022. It sounds like the drug is good and they just need to make it officially marketable.
     

Share This Page